๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vasoactive treatment of hepatorenal syndrome type 1 (HRS1) with midodrine, octreotide and albumin

โœ Scribed by Schepke, Michael; Malayeri, Hamid; Heller, Joerg; Sauerbruch, Tilman


Book ID
122957040
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
240 KB
Volume
124
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Midodrine, octreotide, albumin, and TIPS
โœ Florence Wong; Lavinia Pantea; Kenneth Sniderman ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 167 KB ๐Ÿ‘ 1 views

Hepatorenal syndrome (HRS) is a functional renal disorder complicating decompensated cirrhosis. Treatments to date, except liver transplantation, have been able to improve but not normalize renal function. The aim of this study was to determine the efficacy of transjugular intrahepatic portosystemic